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STAMBP genea b s t r a c t
Background: Microcephaly-capillary malformation (MIC-CAP) syndrome is a newly described autosomal
recessive syndrome characterized by microcephaly, multiple cutaneous capillary malformations, intract-
able epilepsy and profound developmental delay. We present the first description of MIC-CAP syndrome
in Russia.
Patient: We describe a 6-month-old girl with severe congenital microcephaly, intractable epilepsy (infan-
tile spasms), multiple cutaneous capillary malformations and facial abnormalities. Genetic studies
revealed the presence of new STAMPB gene mutations in the compound heterozygous state: c.273delA
and the intron replacement c.204-5 C > G.
Conclusions: This report presents a case of MIC-CAP syndrome with earlier unreported new mutations of
the STAMPB gene.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Microcephaly-capillary malformations (MIC-CAP) syndrome is a
newly described syndrome with an autosomal recessive mode of
inheritance. The primary manifestations of the syndrome are con-
genital microcephaly, intractable epilepsy, multiple cutaneous cap-
illary malformations, facial abnormalities and substantial delays in
psychomotor development. This syndrome was first described by
Carter MT et al. in 2011 [1]. Currently, there are 14 patients known
to have MIC-CAP syndrome. Mutations in the STAMBP gene respon-
sible for disease development have been identified in these patients.
This paper presents the first report of MIC-CAP syndrome in Russia.
2. Clinical report
Our patient is a 6-month-old girl born from the fourth preg-
nancy to unrelated healthy Russian parents. The couple’s first preg-
nancy ended in a medical abortion, the second pregnancy ended in
a miscarriage at 6 weeks, and a healthy boy was born from their
third pregnancy. The parents’ fourth pregnancy was complicated
by a threatened miscarriage at 20 weeks of gestation. Intrauterinegrowth retardation was diagnosed at 30 weeks of gestation. A nor-
mal vaginal delivery occurred at 38 weeks of gestation. Apgar
scores for the infant were 8 at 1 min and 9 at 5 min. Her birth
weight was 2550 g (below 15th percentile), the birth length was
48 cm (below 50th percentile), and the head circumference was
30 cm (below 3rd percentile). At birth, the girl was noted to have
multiple flat vascular stains on the trunk and on the extremities.
She was discharged from the hospital 5 days after birth. The girl
started to hold her head up at the age of 1 month, started to roll
over at 3 months, and did not sit up or crawl.
At 1 month of life, the infant showed failure to thrive with fre-
quent vomiting. At 2 months, she developed paroxysmal events
consisting of a sudden stiffening of the body with arms and head
bending forward for a second (infantile spasms). At the same age,
she became less emotional, she stopped looking after objects and
her head control became worse. At 4 months of life, the frequency
of epileptic seizures increased. The girl stopped holding her head
up, stopped fixing her eyes on objects and stopped smiling.
At 6 months, the girl was admitted to our hospital. On admis-
sion, the child’s condition was critical due to neurological symp-
toms and frequent epileptic seizures. The following phenotypic
features were observed: hypertelorism, a wide nasal bridge, a short
nose, thin lips with drooping mouth corners, a long philtrum, gum
hyperplasia, low-set ears, a short neck, short fingers due to
hypoplasia of distal phalanges, hypoplastic nails and toe malposi-
Fig. 2. The multiple capillary malformations on the trunk.
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mean for her age). Her hair was sparse and had an unusual pattern
of growth with long hair along the sagittal suture forming a
‘‘Mohawk” (Fig. 1). Multiple flat capillary malformations of irregu-
lar shape, measuring 4–15 mm in diameter, were noted on the
scalp, the skin of the trunk and the extremities (Fig. 2). The child
was seriously retarded in psychomotor development: unable to
hold her head, roll, or sit without support. She had roving eye
movements without fixation, myoclonus of eyelids, bulbar syn-
drome, and spastic tetraparesis. On examination, epileptic seizures
in the form of tonic spasms and oculotonic seizures were observed.
Considering the observed features, diagnosis of MIC-CAP syn-
drome was suspected.
A CT brain scan at the age of 3.5 months showed the growing
size of the outer cerebrospinal fluid spaces, which can indicate
an increase in cortical atrophy.
Brain MRI, performed at the age of 5 months, revealed diffuse
cortical atrophy, atrophic ventriculomegaly, and a delay in white
matter myelination (Fig. 3).
An EEG showed abnormally slow background activity, multifo-
cal epileptiform spike-and-wave activity, and a burst suppression
pattern. At the age of 5 months valproic acid was prescribed in
dose 40 mg for each kg of body weight per day, but the frequency
of epileptic seizures did not change.
Her blood amino acids and acyl carnitines, urine organic acids,
lactate level, and TORCH titers were normal. ECG and abdominal
ultrasound examination were unremarkable. Her karyotype was
identified as normal (46,XX).
To establish the genetic cause of MIC-CAP syndrome, we per-
formed a search of mutations by means of direct automated
sequencing of the gene responsible for the disease. Two mutations
were observed in our patient. One mutation was the heterozygous
deletion c.273delA, leading to a frameshift and stop codon forma-
tion in the next triplet.
This deletion is probably highly pathogenic, although it is not
described in the international HGMD database or polymorphisms
database (dbSNP). The intron replacement c.204-5 C > G in the
heterozygous state was also detected in our patient. This intron
replacement has not been described in the international HGMD
database, but according to the data of Human Splicing Finder
pathogenicity program, it can be a splice site mutation and can
be considered to be pathogenic. Thus, the child’s mutations are
in the compound heterozygous state, which results in the forma-
tion of a MIC-CAP syndrome phenotype.
3. Discussion
Since this disease has been described quite recently, and there
are only 14 published cases to date, we want to focus on the char-
acteristics of these cases.Fig. 1. Note unusual hair growth into a ‘‘Mohawk” pattern.The first publication of Canadian pediatricians described two
boys from unrelated families who had similar clinical manifesta-
tions [1]. A unique feature of both children was the presence of
congenital multiple randomly placed red spots (‘‘port-wine stains”)
on the skin, which were the result of abnormal capillary develop-
ment (or capillary malformations). Both patients had progressive
microcephaly, neonatal resistant seizures, psychomotor retarda-
tion, similar craniofacial anomalies, short fingers, and toes with
nail hypoplasia. Brain MRI detected diffuse cortical atrophy, thin-
ning of the corpus callosum, and delayed myelination of the white
matter of the brain in both children. Such a high level of similari-
ties of the phenotypic manifestations in two patients allowed the
authors to classify this condition as a new syndrome. However,
the cause of the syndrome was not clear.
The other case reports from France and the United States
appeared almost simultaneously in the same year. Isidor B. et al.
described the third case with similar symptoms in a girl who had
been observed for 5 years [2]. Mirzaa G.M. et al. from the United
States reported three more cases of the disease from two families
[3]. As there were two children with the same disease within one
family, autosomal recessive inheritance of the disease was
assumed. The syndrome was called microcephaly-capillary malfor-
mation syndrome (MIC-CAP, OMIM 614261).
In all cases, the children showed congenital microcephaly and
multiple capillary malformations on the skin of the trunk, head
and extremities, which increased in size with the growth of the
child. The onset of epileptic seizures in the majority of cases
occurred in the neonatal period. Epileptic seizures were polymor-
phic (focal, tonic, hemiclonic, secondary generalized seizures,
infantile spasms) and were resistant to anticonvulsant therapy
and ketogenic dieting.
All of the children showed a prominent neurological impair-
ment, a rough psychomotor retardation, as well as dysmorphic
facial features, including a receding forehead, low hairline, a round
face, hypertelorism, epicanthal folds, elongated palpebral fissures,
ptosis, a short nose with a broad nasal bridge, low set rotated ears,
high palate, drooping mouth corners, and micrognathia. Several
patients had abnormal hair growth in the form of a ‘‘Mohawk”
Fig. 3. Magnetic resonance imaging of the brain of Patient. Note diffuse symmetric atrophy of cerebral cortex, atrophic ventriculomegaly, delay in white matter myelination.
Table 1
Manifestations of the MIC-CAP syndrome and frequency of symptoms.
Features The case
described
Other data [1–7] %
Gender Female 8 male, 4 female 2M:1F
Congenital microcephaly + 12 100%
Capillary malformations + 12 100%
Low birth weight + 11 91,6%
Early-onset resistant seizures + 11 91,6%
Distinct developmental delay + 11 91,6%
Hypoplasia of distal phalanges + 11 91,6%
Spastic tetraparesis + 10 83,3%
Myoclonus + 6 50%
Craniofacial anomalies, including: + 12 100%
Round face + 4
Hypertelorism + 6
Short wide nose + 5
Drooping lip corners + 3
Low set ears + 3
Short neck + 3
Epicanthus – 3
Ptosis – 2
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absence of distal phalanges and nails, finger malposition, trans-
verse palmar crease, clinodactyly of the fifth finger, and skin syn-
dactyly). Hyperkinesis, myoclonus of the limbs and eyelids, optic
nerve atrophy, divergent strabismus and floating eye movements
have been described in a number of patients.
In one case, sensorineural hearing loss, cleft palate, adrenal
insufficiency, renal anomalies, and cardiac defects were observed.
MRI revealed flattening of the gyri, shallow cerebral fissures, the
immaturity of the white matter, and hypoplasia of the
hippocampus.
In most cases, the disease is severe, primarily due to nervous
system damage. Many children die of septic complications in early
childhood.
Taking into account that MIC-CAP is a rare disease, it is obvious
that every new case of the syndrome is important to clarify the
clinical manifestations of the disease, particularly the identifica-
tion of common and rare symptoms and further evaluation of their
diagnostic significance.
We compared the phenotypic characteristics identified in our
patient with currently known data. Table 1 shows the data on clin-
ical manifestations in our patient and the frequency of the features
identified in the MIC-CAP syndrome according to the results of all
the known descriptions (12 patients).
The high frequency of the features in all described cases allows
us to distinguish the ‘‘core” symptoms, allowing us to diagnose
MIC-CAP syndrome at pre-laboratory stage with a high probability.
Such symptoms may include congenital microcephaly, capillarymalformations, drug-resistant seizures, and typical craniofacial
dysmorphias.
Initially, it was assumed that one or several genes involved in
the processes of vasculogenesis and the regulation of growth are
responsible for the development of MIC-CAP syndrome [3]. How-
ever, mutations in the STAMBP gene (locus 2p13.1) have been
detected after whole exome sequencing of children with this
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sense mutations, 2 nonsense mutations, 2 frameshift mutations
and 3 intron mutations leading to alternative splicing. Identified
pathogenic variants are mostly unique for each family. However,
recurring mutations (p.Arg424Ter [c.1270C > T] p.Phe100Tyr
[c.299T > A] and p.Arg38Cys [c.112C > T]) have also been detected,
indicating the presence of hot spots in the STAMBP gene
(NP_006454.1 and NM_006463.4).
Compound heterozygous pathogenic variants were identified
and confirmed by molecular genetic testing in 9 out of 11 families
with a MIC-CAP diagnosis. In the two remaining families, there was
a homozygous variant (consanguineous marriage) in one case and
a uniparental disomy in the other family [4].
In 2014, a description of the syndrome in two brothers (7 and
12 years old) of Arab origin from a consanguineous marriage was
published. Unlike other cases, the disease was characterized by a
milder course of symptoms (later epilepsy development and less
prominent neurologic impairment) [5]. In addition to the previ-
ously described symptoms, hypothyroidism and autistic behavior
have been detected in these patients. An accurate diagnosis was
confirmed by molecular genetic testing, which identified a
homozygous pathogenic mutation in the STAMBP gene. This case
indicates the variability of the clinical manifestations of MIC-CAP
syndrome. Faqeih EA et al. described an Arab family of two siblings
with classic features of MIC-CAP syndrome, which additionally dis-
play previously unreported findings of congenital hypothyroidism
and alopecia areata [6]. Naseer MI et al. described two brothers
from a consanguineous family of Egyptian ancestry with a
homozygous missense variant in STAMBP (p.K303R) in the two sib-
lings [7].
In our case, the STAMBP gene deletion in a heterozygous state
c.273delA and the intron replacement c.204–5 C > G in a heterozy-
gous state, which are rare in the population according to the ExAcdatabase (0,000865%) and not described in HGMD mutations data-
bases, were identified. Both mutations have been considered
pathogenic. Additionally, the polymorphic variant c.1218
+ 12T > C in a heterozygous state described in the international
polymorphisms database was identified.
In summary, we report a child with recently recognized and
genetically determined MIC-CAP syndrome. This syndrome is char-
acterized by severe congenital microcephaly, diffuse capillary mal-
formations, intractable epilepsy, including infantile spasms, and
severe developmental retardation. In this case, previously
unknown mutations of the STAMBP gene were identified.
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